Rosetta Genomics (Israel)
Rosetta Genomics Ltd. was a molecular diagnostics company with offices in Israel and the United States that uses micro-ribonucleic acid biomarkers to develop diagnostic tests designed to differentiate between various types of cancer. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Rosetta Genomics (Israel), Israel, covering academic research published from 2004 to 2020. Read More.
Open Access Percentage
52%
Total
Publications
88
Total Open
Publications
46
Total
Citations
12K
Open Access
Percentage
52%
Total
Publications
88
Total Open
Publications
46
Total
Citations
12K
Breakdown
Publisher Open
17%
Both
28%
Other Platform Open
7%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
12
Hybrid 33%
13
No Guarantees 37%
15
Other Platform Open
Domain 87%
27
Public 23%
7
Institution 10%
3
Other Internet 3%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 26 |
Europe PMC | Domain | 23 |
Semantic Scholar | Public | 4 |
Figshare | Public | 3 |
University of Oxford - Oxford Academic Notes & Queries | Institution | 1 |
University of Cambridge - Apollo | Institution | 1 |
Politecnico di Torino - PORTO Publications Open Repository TOrino | Institution | 1 |
CiteSeer X | Other Internet | 1 |